{
    "label": "Is this request for starting or continued therapy with Wegovy™ (semaglutide)?",
    "node_type": "fieldset",
    "children": [
        {
            "label": "Starting therapy",
            "outcome": "The requested drug, Wegovy™ (semaglutide), is expected to be covered with prior authorization",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "The requested drug, Wegovy™ (semaglutide), will be used in conjunction with a reduced-calorie diet and increased physical activity for chronic weight management in an adult.",
                    "node_type": "checkbox",
                    "node_value": false
                },
                {
                    "label": "The patient has participated in a comprehensive weight management program that encourages behavioral modification, a reduced calorie diet, and increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy.",
                    "node_type": "checkbox",
                    "node_value": false
                },
                {
                    "label": "The patient's Body Mass Index (BMI) meets one of the following conditions:",
                    "node_type": "checkbox",
                    "node_value": false,
                    "children": [
                        {
                            "label": "The patient has a BMI greater than or equal to 30 kg/m²",
                            "node_type": "checkbox",
                            "node_value": false
                        },
                        {
                            "label": "The patient has a BMI greater than or equal to 27 kg/m² AND has at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)",
                            "node_type": "checkbox",
                            "node_value": false
                        }
                    ]
                }
            ]
        },
        {
            "label": "Continuation of therapy",
            "outcome": "The requested drug, Wegovy™ (semaglutide), is expected to be covered with prior authorization",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "The patient has completed at least 3 months of therapy with the requested drug at a stable maintenance dose",
                    "node_type": "checkbox",
                    "node_value": false
                },
                {
                    "label": "The patient has either:",
                    "node_type": "checkbox",
                    "node_value": false,
                    "children": [
                        {
                            "label": "Lost at least 5 percent of baseline body weight",
                            "node_type": "checkbox",
                            "node_value": false
                        },
                        {
                            "label": "Continued to maintain their initial 5 percent weight loss",
                            "node_type": "checkbox",
                            "node_value": false
                        }
                    ]
                },
                {
                    "label": "Documentation of the above weight loss is provided.",
                    "node_type": "checkbox",
                    "node_value": false
                }
            ]
        }
    ]
}